The global In Vitro Diagnostics (IVD) Quality Control Market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period. Continually evolving technology-oriented changes in the diagnostics field and growing need to ensure patient safety necessitate the implementation of quality assurance programs in various medical disciplines including radiology and Point-of-Care (PoC) devices. Patients rely on self-testing IVD devices for long-term disease management and hence it is important for such devices to be checked, in terms of result reproducibility and validity, to guarantee patient safety.
Rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the market. In addition to quality assessments, amendments to the regulatory framework are made intermittently to enhance the existing standards with the main objective of safeguarding qualitative superiority of the diagnostic services. In May 2016, the European Union passed an agreement to update the pre-existing regulations pertaining to IVD devices, wherein the updates were in concern with raising the patient safety levels, particularly for disabled persons. The presence of third-party agencies for independent assessment of the IVD devices is expected to elevate the current safety standards, which will drive the In Vitro Diagnostics (IVD) Quality Control market further.
Request a Sample Copy of the Global In Vitro Diagnostics Quality Control Market Research Report @ https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market/request/rs1
Further key findings from the study suggest:
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/2967/ibb
Grand View Research has segmented the global IVD quality control market on the basis of application, type, end use, and region:
IVD Quality Control Application Outlook (Revenue, USD Million, 2014 – 2026)
IVD Quality Control Type Outlook (Revenue, USD Million, 2014 – 2026)
IVD Quality Control End Use Outlook (Revenue, USD Million, 2014 – 2026)
IVD Quality Control Regional Outlook (Revenue, USD Million, 2014 – 2026)
Browse Related Category @
Clinical Microbiology Market: The global clinical microbiology market size was valued at USD 9.1 billion in 2016 and is expected to develop at a healthy CAGR over the forecast period.
Molecular Diagnostics Market: Advancements in molecular diagnostics have enabled detection of various diseases that could possibly reduce social and economic burden in a country.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market